NGS Based RNA Seq Market Revenue to Cross USD 7,984.90 Million by 2027 says, The Insight Partners

The NGS-based RNA seq market was valued at US$ 1,414.59 million in 2018 and it is projected to reach US$ 7,984.90 million in 2027; it is expected to grow at a CAGR of 19.3% from 2018 to 2027.

The NGS Based RNA Seq Market report provides a basic overview of the market including definitions, classifications, applications and industry chain structure. The NGS Based RNA Seq Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.

Download Sample PDF at https://www.theinsightpartners.com/sample/TIPBT00002556?utm_source=OpenPR&utm_medium=10786

Key Players Analysis:
Thermo Fisher Scientific Inc.
Illumina Inc.
Pacific Biosciences of California, Inc.
F. Hoffman-La Roche Ltd
Agilent Technologies
BGI
Oxford Nanopre Technologies
Eurofins Scientific
Qiagen
Perkinelmer Inc.

The report covers key developments in the NGS Based RNA Seq Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from NGS Based RNA Seq Market are anticipated to have lucrative growth opportunities in the future with the rising demand for NGS Based RNA Seq Market in the global market. Below mentioned is the list of few companies engaged in the NGS Based RNA Seq Market.

Research report has been compiled by studying the market in-depth along with drivers, opportunities, restraints & other strategies as well as new-developments that can help a reader to understand the exact situation of the market along with the factors that can limit or hamper the market growth and the report also has been updated with Impacts & effects of Coronavirus pandemic and how it has influenced consumer behaviour & the growth of the market as well as industries.

MARKET SEGMENTATION
In terms of product & services, the global NGS-based RNA seq market is segmented into sample preparation, sequencing services, sequencing platforms & consumables and data analysis, storage & management. In 2018, the sequencing platforms & consumables segment held largest share of the market. However, the data analysis, storage & management segment is estimated to register the highest CAGR during the forecast period.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the NGS Based RNA Seq Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2030 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The NGS Based RNA Seq Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

Get a Full Report Copy @ https://www.theinsightpartners.com/buy/TIPBT00002556?utm_source=OpenPR&utm_medium=10786

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Eye Drops, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.